Careers

WHY PATHOQUEST

We drive innovation in quality testing allowing our customers to develop and deliver new biotherapies rapidly and safely to patients. 

Innovative biologics must be manufactured to the highest standards of safety and in a timely manner. That’s why PathoQuest has built an extensive team of genomic experts to support our clients with rapid and robust quality controlled (QC) testing at GMP and non-GMP level. 

Our goal is to transform the future of QC testing for biologic therapies and treatments that improve patient lives.  However, we can only achieve this goal by focusing on what matters:  teamwork, innovation expertise, speed and quality.

 These new biotherapies are quite literally transforming and often saving lives, and we are privileged to play our part in getting these new treatments to patients. 

OPEN ROLES

If you are interested in what we do and believe you have the passion, experience and expertise to join the PathoQuest team, please send your CV or resume along with a covering letter to office@pathoquest.com

News & Events

Replacing MAP/HAP/RAP with iDTECT® Transcriptome Assay

Replacing Mouse, Rat and Hamster Antibody Production Tests (MAP/RAP/HAP) with NGS iDTECT®  Transcriptome assay.  Further PathoQuest data to support the switch to iDTECT® NGS for faster, safer, animal free release of cell banks is now available !  The ICH...

read more

Contact us

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

E: contact@pathoquest.com

Sign up for our latest news

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

E: contact@pathoquest.com

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

Sign up for our latest news